Full operations have been resumed from 19 June 2020.
In view of the Covid-19 situation, enhanced precautionary measures are in place to ensure the safety and well-being of our patients.
Read more >>

Dengue Vaccine to Protect Yourself Against Subsequent Dengue Infections

What is Dengue?

Dengue fever is a disease caused by the dengue virus, which is transmitted by female mosquitoes mainly of the species Aedes aegypti. There are four serotypes of the virus that cause dengue — DENV-1, DENV-2, DENV-3 and DENV-4. Hence, individuals can be infected with dengue up to four times.

First time dengue infection is believed to provide lifelong immunity against that serotype. However, subsequent dengue infections by other serotypes may have high risk of developing severe dengue,
dengue haemorrhagic fever or dengue shock syndrome, which can be life-threatening.

Symptoms of Severe Dengue

Severe dengue, dengue haemorrhagic fever and dengue shock syndrome are dengue infections that become severe and potentially have fatal complications, which often require hospitalization. Symptoms of severe dengue generally develop after the fever has gone down, followed by:

Severe Dengue Symptoms Infographics

  • Severe bleeding such as gum bleeding, nose bleeding, bleeding into the skin and organs
  • Abdominal pain
  • Persistent vomiting
  • Rapid breathing
  • Fatigue
  • Restlessness
  • Blood in vomit
  • Death


If you think you have dengue, consult your doctor and seek medical attention immediately.

Dengue Cases in Singapore

Singapore has the highest dengue cases in 2020, with a cumulative number of cases at more than 32,000 as of 19 October 2020. The number has surpassed the 22,170 cases in 2013, which was the previous largest dengue outbreak in Singapore.

20 people have died from dengue in Singapore, as of 2 August 2020.

The Dengue Vaccine

There is no specific treatment for dengue fever, severe dengue, dengue haemorrhagic fever and dengue shock syndrome. Fortunately, there are supportive therapies in Singapore and also dengue vaccine, Dengvaxia, available for the prevention of subsequent dengue infections. Dengvaxia dengue vaccine has been approved by Health Sciences Authority (HSA).

Dengue Vaccine

Who is suitable?

  • For individuals above 12 years of age, with previous dengue infection
  • For individuals not previously infected by dengue virus, vaccination is not recommended as an increased risk of hospitalization for dengue and severe dengue has been observed


How do I check for previous dengue infection?

  • Serologic test is mandatory for all individuals before getting a vaccine
  • Serologic test is a blood test to identify previous dengue infection or individuals with an unknown history of previous dengue infection


How is the vaccine given?

  • The vaccine will be injected underneath the skin in the upper arm
  • The vaccination includes 3 injections of 0.5ml each over a period of 12 months, with 6-months intervals at month 0, 6 and 12
  • 3 injections are needed to obtain optimal benefit of the vaccine so it is important not to miss any doses


What are the precautions to note?

  • Do not use Dengvaxia if you:
    • Do not have a prior dengue infection,
    • Are allergic to the active substances or prior administration of any vaccines,
    • Have a weakened immune system,
    • Are suffering from a disease with mild to high fever or acute disease,
    • Are pregnant,
    • Are breastfeeding.

Is Dengvaxia Effective?

HSA’s regulatory approval is based on a review of the 24 clinical studies conducted by Sanofi in over 41,000 subjects. The evaluation are:

  • Dengvaxia has an efficacy of 60% in reducing dengue illness, and 84% in reducing severe dengue illness.
  • It is especially effective in protecting against DENV-3 and DENV-4, showing an efficacy of 75% and 77% respectively.
  • It has shown in providing significantly better protection to those who had a prior exposure to dengue with an efficacy of 81%.
  • Results have shown that it is effective up to four years from the administration of the last dose.

Source: https://www.hsa.gov.sg/announcements/news/hsa-approves-dengvaxia-vaccine

If you have any questions on the Dengvaxia dengue vaccine, you may make an appointment to consult our doctors at Thomson Wellth Clinic.

Thomson Wellth Dengue Vaccination

Share this post

Share on facebook
Share on twitter

Related Articles

Say Goodbye to Sagging Skin

As we age, our skin loses collagen, a protein that gives skin its firmness and elasticity. You will start to notice it becoming saggy and crinkly. INDIBA Radiofrequency treatment can help prevent age-associated skin sagging, and restore your skin’s health.

Read More